XSHE
002612
Market cap709mUSD
Jul 09, Last price
10.88CNY
1D
-1.27%
1Q
-34.89%
Jan 2017
-34.24%
IPO
-42.27%
Name
Lancy Co Ltd
Chart & Performance
P/E
4.82
P/S
0.80
EPS
2.26
Div Yield, %
3.68%
Shrs. gr., 5y
—
Rev. gr., 5y
9.39%
Revenues
6.00b
+5.48%
Net income
999m
+288.52%
CFO
445m
-21.42%
Dividend
May 22, 20250.4 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Lancy Co., Ltd. is primarily engaged in the design, manufacturing, and marketing of branded women's apparel. The company's fashion portfolio includes various labels such as LANCYFROM25, LIMEFLARE, liaalancy, MOJOS.PHINE, JIGOTT, FABIANAFILIPPI, and m.tsubomi. Beyond its core fashion operations, Lancy has diversified into the medical aesthetics and healthcare sector. This includes overseeing and running medical institutions under the Milan Boyu brand, providing specialized laser and minimally invasive cosmetic treatments through its medical youth brand, and managing comprehensive aesthetic centers. These Gaoyisheng Medical Beauty centers offer a broad spectrum of services, ranging from cosmetic surgery and dermatological care to traditional Chinese aesthetic medicine, cosmetic dentistry, and micro-plastic procedures. Additionally, the company supplies clothing for infants and children, featuring popular brands like Agabang, ETTOI, Putto, Designskin, and DearBaby. Lancy distributes its wide array of products through both its physical retail stores and various online channels. The company was founded in 2000 and is headquartered in Beijing, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||